{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:56:55Z","timestamp":1744520215034},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13256-015-0517-8","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T11:22:01Z","timestamp":1425036121000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Castleman\u2019s disease and sarcoidosis, a rare association resulting in a \u201cmixed\u201d response: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Anwarullah","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Janku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"key":"517_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1056\/NEJM195409022511008","volume":"251","author":"B Castleman","year":"1954","unstructured":"Castleman B, Towne VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med. 1954;251:396\u2013400.","journal-title":"N Engl J Med"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/02841860410002752","volume":"43","author":"A Waterston","year":"2004","unstructured":"Waterston A, Bower M. Fifty years of multicentric Castleman\u2019s disease. Acta Oncol. 2004;43:698\u2013704.","journal-title":"Acta Oncol"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MAJ.0b013e31820376e3","volume":"341","author":"BL Rice","year":"2011","unstructured":"Rice BL, Farver CF, Pohlman B, Burkey BB, Parambil JG. Concomitant Castleman\u2019s disease and sarcoidosis. Am J Med Sci. 2011;341:257\u20139.","journal-title":"Am J Med Sci"},{"key":"517_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","volume":"15","author":"F van Rhee","year":"2014","unstructured":"van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fossa A, et al. Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15:966\u201374.","journal-title":"Lancet Oncol"},{"key":"517_CR5","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","volume":"28","author":"F Van Rhee","year":"2010","unstructured":"Van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, et al. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman\u2019s disease. J Clin Oncol. 2010;28:3701\u20138.","journal-title":"J Clin Oncol"},{"key":"517_CR6","first-page":"378","volume":"11","author":"MA Bhatti","year":"1984","unstructured":"Bhatti MA, Ferrante JW, Gielchinsky I, Norman JC. Giant lymph node hyperplasia of the mediastinum (Castleman\u2019s disease). Tex Heart Inst J. 1984;11:378\u201384.","journal-title":"Tex Heart Inst J"},{"key":"517_CR7","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.4081\/rt.2010.e11","volume":"2","author":"MA Regal","year":"2010","unstructured":"Regal MA, Aljehani YM, Bousbait H. Primary mediastinal Castleman\u2019s disease. Rare Tumors. 2010;2:e11.","journal-title":"Rare Tumors"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12185-011-0812-0","volume":"93","author":"Y Tal","year":"2011","unstructured":"Tal Y, Haber G, Cohen MJ, Phillips M, Amir G, Ben-Yehuda D, et al. Autologous stem cell transplantation in a rare multicentric Castleman disease of the plasma cell variant. Int J Hematol. 2011;93:677\u201380.","journal-title":"Int J Hematol"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1634\/theoncologist.2010-0212","volume":"16","author":"HE El-Osta","year":"2011","unstructured":"El-Osta HE, Kurzrock R. Castleman\u2019s disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16:497\u2013511.","journal-title":"Oncologist"},{"key":"517_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1056\/NEJM199403033300904","volume":"330","author":"JT Beck","year":"1994","unstructured":"Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman\u2019s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994;330:602\u20135.","journal-title":"N Engl J Med"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/MPH.0b013e3181b2708f","volume":"31","author":"N Toita","year":"2009","unstructured":"Toita N, Kawamura N, Hatano N, Takezaki S, Ohkura Y, Yamada M, et al. A 5-year-old boy with unicentric Castleman disease affecting the mesentery: utility of serum IL-6 level and (18)F-FDG PET for diagnosis. J Pediatr Hematol Oncol. 2009;31:693\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"517_CR12","first-page":"813","volume":"51","author":"SL Han","year":"2010","unstructured":"Han SL, Chen XX, Zheng XF, Yan JY, Shen X, Zhu GB. The clinicopathological behaviour and surgical treatment of abdominal Castleman\u2019s disease. Singapore Med J. 2010;51:813\u20136.","journal-title":"Singapore Med J"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.clindermatol.2007.03.010","volume":"25","author":"PR Cohen","year":"2007","unstructured":"Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007;25:326\u201333.","journal-title":"Clin Dermatol"},{"key":"517_CR14","first-page":"176","volume":"85","author":"S Oliwiecki","year":"1992","unstructured":"Oliwiecki S, Kotecha B, Kingston T, Rothera MP. Sarcoidosis-lymphoma syndrome. J R Soc Med. 1992;85:176\u20137.","journal-title":"J R Soc Med"},{"key":"517_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1378\/chest.106.1.156","volume":"106","author":"K Sahashi","year":"1994","unstructured":"Sahashi K, Ina Y, Takada K, Sato T, Yamamoto M, Morishita M. Significance of interleukin 6 in patients with sarcoidosis. Chest. 1994;106:156\u201360.","journal-title":"Chest"},{"issue":"36","key":"517_CR16","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1158\/1078-0432.CCR-12-3349","volume":"19","author":"R Kurzrock","year":"2013","unstructured":"Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, et al. A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman Disease. Clin Cancer Res. 2013;19(36):3659-70.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-015-0517-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0517-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:06:37Z","timestamp":1630573597000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-015-0517-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s13256-015-0517-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]},"assertion":[{"value":"15 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}